Investor profile
Laura Davis
Syndicate / Angel group, Venture capital & Co-Chair, National Health Care Group at Golden Seeds
Laura Davis is a Co-Chair, National Health Care Group at Golden Seeds, whose known portfolio counts 10 companies.
Is Laura Davis a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
- Focus
- BiotechDataDiagnosticsDigital HealthE-CommerceEventsFashionFemale-Focused Consumer GoodsLife ScienceMarketplacesMedTechTherapeutics
Contacts
Affiliated funds' portfolios
Co-Chair, National Health Care Group at Golden Seeds, whose known portfolio counts 10 companies
- Avisi Technologies
- Cooler Heads
- EliseAI
- PolyGone Systems
- Chippin
- Every Body Eat
- Bairitone Health
- Canvas Construction
- NanoPattern Technologies
- Nullspace
Investor Profile
Founders in the listed sectors AI, Commerce, Consumer and Education, and focus areas Biotech, Data, Diagnostics and Digital Health fall inside that listing.
Stage-wise, the deals at Golden Seeds cluster around Pre-Seed, Seed and Series A rounds.
What the affiliated firm has backed is the closest available signal on whether Laura Davis is worth approaching.
Colleagues at Golden Seeds
Showing 20 of 75
Jean Hammond
Member of Boston Forum
Boston, United States
Jo Ann Corkran
Co-Chief Executive Officer
New York, United States
Kathleen Coviello
Member
Trenton, United States
Sheila Narayan
Golden Seeds Alum / Former Managing Director
Boston, United States
Gail Hoffman
Managing Director
West Newton, United States
Laura Baldwin
Managing Director
Dallas, United States
Sandy Kresch
Managing Director
Washington, United States
Josephina Kim
Managing Director
New York City, United States
Iris Fujiura
Mentor, coach, speaker, investor
Oakland, United States
Loretta McCarthy
Co-Chief Executive Officer and Managing Partner
New York, United States
Robert Delman
Managing Director
New York, United States
Jackie Magno
Managing Director
Portola Valley, United States
Mindy Posoff
Managing Director
New York, United States
Carol McNierney
Managing Director
New York City, United States
Paula Bennett
Managing Director
New York City, United States
Petra Meyer
Co-Lead
New York, United States
Matias Healy
Venture Fund Sr. Analyst
New York, United States
Eric Nadler
Managing Director, B2C Sector Leader
Briarcliff Manor, United States
Irina Berkon
Managing Director
San Francisco, United States
Cheryl Kallem
Managing Director
New York, United States
Frequently asked questions
Who is Laura Davis?
Laura Davis is a syndicate member and venture capital investor based in Boston, Massachusetts, United States, listed as Co-Chair, National Health Care Group at Golden Seeds. The known portfolio of that firm counts 10 companies. That portfolio belongs to the firm, not to Laura Davis personally.
What does Laura Davis invest in?
Listed sectors include AI, Commerce, Consumer and Education; listed focus areas include Biotech, Data, Diagnostics and Digital Health. Those tags come from the portfolios of the firms this profile is attached to, so they read as a record of what has been backed rather than a stated preference for what comes next.
What stage does Laura Davis invest at?
Golden Seeds appears in Pre-Seed, Seed and Series A rounds across its known deals, and Laura Davis is listed there as Co-Chair, National Health Care Group. Stage is the strongest single filter when you build a target list: an investor with no record at your stage rarely starts with you.
Which firm is Laura Davis listed at?
Laura Davis is listed as Co-Chair, National Health Care Group at Golden Seeds. 75 other people in the database share a firm with Laura Davis.
How do I contact Laura Davis?
An email address, a phone number and a LinkedIn page are on file for Laura Davis. The address stays masked on this page and is readable inside RaiseHunt after you create an account.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal